18-62325354-T-C

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2

The NM_003839.4(TNFRSF11A):​c.2T>C​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000114 in 875,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000011 ( 0 hom. )

Consequence

TNFRSF11A
NM_003839.4 start_lost

Scores

2
6
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.538

Publications

0 publications found
Variant links:
Genes affected
TNFRSF11A (HGNC:11908): (TNF receptor superfamily member 11a) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptors can interact with various TRAF family proteins, through which this receptor induces the activation of NF-kappa B and MAPK8/JNK. This receptor and its ligand are important regulators of the interaction between T cells and dendritic cells. This receptor is also an essential mediator for osteoclast and lymph node development. Mutations at this locus have been associated with familial expansile osteolysis, autosomal recessive osteopetrosis, and Paget disease of bone. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Aug 2012]
TNFRSF11A Gene-Disease associations (from GenCC):
  • Paget disease of bone 2, early-onset
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal recessive osteopetrosis 7
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • familial expansile osteolysis
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • dysosteosclerosis
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
  • osteosarcoma
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 9 pathogenic variants. Next in-frame start position is after 56 codons. Genomic position: 62349820. Lost 0.090 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFRSF11ANM_003839.4 linkc.2T>C p.Met1? start_lost Exon 1 of 10 ENST00000586569.3 NP_003830.1 Q9Y6Q6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFRSF11AENST00000586569.3 linkc.2T>C p.Met1? start_lost Exon 1 of 10 1 NM_003839.4 ENSP00000465500.1 Q9Y6Q6-1
TNFRSF11AENST00000269485.11 linkc.2T>C p.Met1? start_lost Exon 1 of 7 1 ENSP00000269485.7 Q9Y6Q6-2
TNFRSF11AENST00000592013.1 linkn.29T>C non_coding_transcript_exon_variant Exon 1 of 2 2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000114
AC:
1
AN:
875402
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
412206
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
16476
American (AMR)
AF:
0.00
AC:
0
AN:
2676
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6162
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5284
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2938
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1788
European-Non Finnish (NFE)
AF:
0.00000126
AC:
1
AN:
791874
Other (OTH)
AF:
0.00
AC:
0
AN:
29390
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Dec 08, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects the initiator methionine of the TNFRSF11A mRNA. The next in-frame methionine is located at codon 56. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TNFRSF11A-related conditions. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
21
DANN
Benign
0.56
DEOGEN2
Benign
0.048
.;.;.;.;T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.082
N
LIST_S2
Uncertain
0.90
D;D;D;D;D
M_CAP
Pathogenic
0.75
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D
MetaSVM
Benign
-1.1
T
PhyloP100
0.54
PROVEAN
Benign
-0.21
.;N;.;.;.
REVEL
Uncertain
0.29
Sift
Uncertain
0.0050
.;D;.;.;.
Sift4G
Uncertain
0.016
.;D;D;D;D
Polyphen
0.33
.;.;.;.;B
Vest4
0.63, 0.58, 0.66, 0.55
MutPred
0.99
Gain of phosphorylation at M1 (P = 0.0097);Gain of phosphorylation at M1 (P = 0.0097);Gain of phosphorylation at M1 (P = 0.0097);Gain of phosphorylation at M1 (P = 0.0097);Gain of phosphorylation at M1 (P = 0.0097);
MVP
0.94
ClinPred
0.25
T
GERP RS
1.6
PromoterAI
-0.25
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.43
gMVP
0.41
Mutation Taster
=29/171
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr18-59992587; API